Senestech (NASDAQ:SNES) Stock: Insider Glenbrook Capital Management Acquires 36,375 Shares

Senestech, Inc. (NASDAQ:SNES) major shareholder Glenbrook Capital Management acquired 36,375 shares of the firm’s stock in a transaction that occurred on Tuesday, October 20th. The shares were purchased at an average cost of $0.67 per share, with a total value of $24,371.25. Following the completion of the acquisition, the insider owned 2,099,473 shares in the company, valued at $1,406,646.91. This trade represents a 1.76% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Large shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Glenbrook Capital Management also recently made the following trade(s):

• On Thursday, October 22nd, Glenbrook Capital Management bought 7,500 shares of Senestech stock. The stock was purchased at an average price of $0.80 per share, for a total transaction of $6,000.00.
• On Wednesday, October 21st, Glenbrook Capital Management bought 60,000 shares of Senestech stock. The stock was purchased at an average price of $0.74 per share, for a total transaction of $44,400.00.
• On Monday, October 19th, Glenbrook Capital Management bought 376,552 shares of Senestech stock. The stock was purchased at an average price of $0.70 per share, for a total transaction of $263,586.40.
• On Friday, October 16th, Glenbrook Capital Management bought 181,252 shares of Senestech stock. The shares were purchased at an average cost of $0.63 per share, with a total value of $114,188.76.
• On Thursday, October 15th, Glenbrook Capital Management bought 426,000 shares of Senestech stock. The shares were purchased at an average cost of $0.77 per share, with a total value of $328,020.00.
• On Friday, August 7th, Glenbrook Capital Management purchased 6,490 shares of Senestech stock. The shares were purchased at an average price of $1.30 per share, with a total value of $8,437.00.
• On Thursday, August 6th, Glenbrook Capital Management purchased 15,000 shares of Senestech stock. The shares were purchased at an average price of $1.30 per share, with a total value of $19,500.00.

Senestech Trading Up 5.1%

Shares of NASDAQ:SNES opened at $0.84 on Friday. The company has a market cap of $4.56 million, a P/E ratio of -0.61 and a beta of 0.25. The stock’s 50-day moving average is $0.88 and its 200-day moving average is $1.31. Senestech, Inc. has a 52-week low of $0.55 and a 52-week high of $3.85. The company has a debt-to-equity ratio of 0.02, a quick ratio of 5.81 and a current ratio of 6.78.

Senestech (NASDAQ:SNES) last posted its quarterly earnings data on Wednesday, August 5th. The company reported ($0.35) EPS for the quarter, topping analysts’ consensus estimates of ($0.37) by $0.02. Senestech had a negative return on equity of 71.89% and a negative net margin of 294.73%. The business had revenue of $0.77 million for the quarter, compared to analyst estimates of $0.60 million. Equities research analysts predict that Senestech, Inc. will post -1.28 earnings per share for the current year.

Hedge Funds Weigh In On Senestech

An institutional investor recently bought a new position in Senestech stock. Diversify Wealth Management LLC bought a new position in shares of Senestech, Inc. (NASDAQ:SNES) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 19,119 shares of the company’s stock, valued at approximately $31,000. Diversify Wealth Management LLC owned 0.36% of Senestech at the end of the most recent quarter. 5.19% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings lowered Senestech from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, August 11th. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the company has a consensus rating of “Sell”.

Senestech Company Profile

SenesTech, Inc is a life sciences company focused on developing fertility-control technologies for managing pest populations. The company’s approach is designed to reduce the reproduction of rodents rather than relying solely on traditional lethal control methods.

SenesTech’s primary product is ContraPest, a liquid bait formulated to target the fertility of both male and female rats. The product is intended for use in settings such as commercial facilities, urban areas, agricultural operations and other locations where rodent populations can create health, safety or economic risks.